Trexquant Investment LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 127 filers reported holding TG THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,264,639
-9.0%
390,507
+170.3%
0.08%
-12.8%
Q2 2023$3,589,007
-21.5%
144,485
-62.6%
0.09%
-27.7%
Q4 2022$4,571,905
+2087.5%
386,467
+992.7%
0.13%
+1757.1%
Q3 2022$209,000
-54.7%
35,369
-14.8%
0.01%
-74.1%
Q4 2019$461,000
+62.9%
41,522
+92.9%
0.03%
+35.0%
Q2 2018$283,000
-76.8%
21,522
-75.0%
0.02%
-76.5%
Q1 2018$1,220,000
+121.4%
85,943
+27.8%
0.08%
+41.7%
Q4 2017$551,000
+108.7%
67,243
+54.2%
0.06%
+71.4%
Q2 2016$264,000
-7.7%
43,609
+82.1%
0.04%
+40.0%
Q4 2015$286,000
-44.9%
23,950
-23.5%
0.02%
-56.9%
Q2 2015$519,00031,3000.06%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders